The uterine fibroid treatment market was USD 3,121.1 million in 2022, which will touch USD 6,714.4 million, advancing at a 10.1% compound annual growth rate, by 2030. The progression of this industry is because of the increasing count of patients with uterine fibroids, the rising incidence of hormonal conditions in females, and the mounting female elderly population. In 2022, the … Continua a leggere→